@Pharmacist, 4 "Golden Ideas" for Seizing Market Opportunities in the Pharmaceutical Equipment Industry

The pharmaceutical equipment industry is the upstream of pharmaceutical companies and a very basic facility for major pharmaceutical companies
.
In recent years, with the advancement of medical reform policies such as centralized procurement and consistency evaluation, as well as the rise of biotechnology, the needs and requirements of pharmaceutical companies for pharmaceutical equipment are changing, with greater demand and higher requirements
.
Data shows that the current market size of China's pharmaceutical equipment industry has reached 100 billion yuan, and it is expected to reach 200 billion yuan by 2025, which shows that the pharmaceutical machine market has considerable prospects
.
Pharmaceutical equipment industry (Photo source: Pharmaceutical Network) So, for pharmaceutical machine companies, how to seize future opportunities? Some pharmaceutical machine companies have already seized new opportunities in the market
.
The 2021 performance forecast shows that the revenue and profit of Chutian Technology in 2021 will be 5 billion and 500 million respectively, while in 2020 only about 1 billion and 100 million yuan; Tofflon's 2021 pre-profit is 765 million to 904 million yuan , a year-on-year increase of 65%-95%; Xinhua Medical is expected to achieve a net profit of 530 million yuan to 636 million yuan in 2021, a year-on-year increase of 126.
36% to 171.
63%
.
Some analysts believe that there may be some "golden ideas" from industry giants with high market shares such as Chutian Technology and Tofflon, which can be summarized as the following four points
.
Increase investment in R&D Guohai Securities once pointed out in an in-depth report on the pharmaceutical equipment industry that R&D determines that the pharmaceutical equipment industry will usher in multiple strategic incremental opportunities in the future
.
At present, the domestic pharmaceutical equipment industry has begun to usher in a long-term growth period, and the low-level R&D and low-level repetitive production models have been unable to adapt to the rapid changes and demands of the market
.
In recent years, pharmaceutical machine giants including Chutian Technology and Tofflon have invested heavily in product research and development
.
For example, Chutian Technology invested 2.
878 billion yuan in research and development in 2020, accounting for about 8% of its revenue; Tofflon invested 1.
561 billion yuan in research and development, accounting for 5.
77% of the company's total revenue..
The industry pointed out that there is still a big gap between the R&D investment level of domestic pharmaceutical machine giants and foreign giants.
Therefore, this aspect is also an issue that enterprises and industries need to pay attention to.
Only by raising the level of R&D to a certain height can domestic production be realized The innovation of pharmaceutical machines further promotes the transformation of domestic pharmaceutical equipment from low-end to mid-to-high-end
.
Strengthening technology improvement Parts are important components of pharmaceutical equipment, and the level of technology determines the level of equipment
.
Judging from the overall situation of parts and components in the pharmaceutical equipment industry, many parts and core technologies still rely on imports, which are limited by people
.
With the advancement of China's "14th Five-Year Plan", "Made in China 2025" and "Industry 4.
0", the industry expects that the pace of import substitution of domestic machinery parts may accelerate in the future
.
On the track of pharmaceutical equipment, pharmaceutical machine companies that give priority to self-made, have core technologies, and conform to the new direction of market development will gain opportunities
.
For example, Chutian Technology already has an advantageous production and processing system and management system in the industry, and most of its core components are self-made to control product quality
.
The company has also cooperated with ROMACO to actively carry out management changes and technical docking to improve production quality, which is expected to promote the company's product technology to achieve step-by-step progress
.
Tofflon is also actively focusing on the development strategy of "systematization, internationalization, and digital intelligence" under the background of the current pharmaceutical companies' increasing requirements for automation and intelligence
.
It is reported that at the large-scale special recruitment fair in the spring of 2022 in Ningxiang Economic and Technological Development Zone recently, Chutian Technology has released many recruitment positions, including mechanical engineers, electrical engineers, process engineers, test engineers, international/domestic debugging engineers, International/domestic project manager, biological consumables sales representative, international/domestic sales manager, sales support manager, argon welder, assembly electrician, assembly fitter, milling/turning, CNC programming engineer, sheet metal worker/bender, machining fitter, Plumbers, riveters, quality engineers,
etc.
At the end of 2021, Tofflon also released a number of recruitment information, and the recruitment positions include sales manager, international marketing specialist, international recruitment supervisor/senior commissioner, international business development manager, international service engineer, etc. .
In the recruitment introduction, Tofflon stated that the company is conducting domestic and overseas job recruitment according to its international business development needs, to meet the employment needs in a timely manner
.
Judging from the active "recruitment" of the pharmaceutical machine giants, the pharmaceutical machine industry enterprises are paying more and more attention to the importance of talents in the process of actively expanding the domestic and international markets.
At the same time, the development of the industry requires more knowledge of both medicine and medicine The addition of high-level talents of equipment
.
As the so-called war in the 21st century is a battle for talents, in the context of the coexistence of opportunities and challenges in the pharmaceutical machine market, talents will play a pivotal role in the development of enterprises
.
Capacity Expansion In the face of the considerable market blue ocean of pharmaceutical equipment, if pharmaceutical equipment companies want to embrace opportunities, they also need to be able to cope with the challenges of capacity expansion
.
For example, pharmaceutical machine companies including Chutian and Tofflon are actively expanding their production capacity
.
Among them, Chutian Technology has successively implemented several strategic mergers and acquisitions since its listing.
The upstream and downstream of the industrial chain have continued to expand, and the factory area has continued to expand.
At the same time, the company is also building new factories.
In 2020, the company's production capacity will be expanded.
The two projects, the intelligent equipment manufacturing science and technology innovation industrial park project and the biopharmaceutical system equipment industrialization project, are expected to invest a total of 850 million yuan
.
In addition, the industrialization project invested by the company in Jinshan Industrial Zone is expected to be put into production this year
.